Naglla Elimam

FLAG/FLAG-IDA regimen for children with relapsed/refractory acute leukemia in the era of targeted novel therapies

Omima Mustafa, Khalid Abdalla, Aeshah AlAzmi et al. · Journal of Oncology Pharmacy Practice · 2018 · 25 citations

Medicine, Oncology, Pediatrics +17

Identifying causes of variability in outcomes in children with acute lymphoblastic leukemia treated in a resource‐rich developing country

Wasil Jastaniah, Naglla Elimam, Khalid Abdalla et al. · Pediatric Blood & Cancer · 2014 · 12 citations

Medicine, Oncology, Pediatrics +11

Early vs. late MRD response- and risk-based treatment intensification of childhood acute lymphoblastic leukemia: a prospective pilot study from Saudi Arabia

Wasil Jastaniah, Naglla Elimam, Khalid Abdalla et al. · Experimental Hematology and Oncology · 2018 · 12 citations · Full text

Medicine, Oncology, Pediatrics +17

The prognostic significance of hypertension at diagnosis in children with wilms tumor

Wasil Jastaniah, Naglla Elimam, Razan S. Alluhaibi et al. · Saudi Medical Journal · 2017 · 11 citations · Full text

Medicine, Oncology, Pediatrics +16

Outcomes of blinatumomab based therapy in children with relapsed, persistent, or refractory acute lymphoblastic leukemia: a multicenter study focusing on predictors of response and post-treatment immunoglobulin production

Mohammed Essa, Reem Abdellatif, Naglla Elimam et al. · Pediatric Hematology and Oncology · 2022 · 11 citations

Medicine, Hematology, Pediatrics +16